Open Access

The function of MMP‑28/TGF‑β induced cell apoptosis in human glioma cells

  • Authors:
    • Xuepeng Wang
    • Xi Chen
    • Lin Sun
    • Xiaoli Bi
    • Haitao He
    • Lei Chen
    • Jinfeng Pang
  • View Affiliations

  • Published online on: August 2, 2018     https://doi.org/10.3892/etm.2018.6566
  • Pages: 2867-2874
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to assess the expression status of matrix metalloproteinase (MMP)‑28 and to investigate its molecular mechanisms in glioma cells. MicroRNA (miRNA) reverse transcription‑quantitative polymerase chain reaction was used to analyze the expression of MMP‑28 and transforming growth factor (TGF)‑β expression in glioma patients and healthy volunteers. MTT and Transwell assays were conducted to determine cell growth and metastasis, respectively. Annexin V/propidium iodide staining was also employed to measure cell apoptosis. MMP‑28 and TGF‑β protein expression were measured using western Blot analysis. The results indicated that MMP‑28 and TGF‑β expression was downregulated in glioma patients, when compared with the normal group. Overall survival and disease‑free survival of patients with a low expression of MMP‑28 were lower than those with high MMP‑28 expression. Overexpression of MMP‑28 induced TGF‑β protein expression, while downregulation of MMP‑28 suppressed TGF‑β protein expression in glioma cell. The downregulation of MMP‑28 reduced the cell growth and apoptosis of glioma cell via the suppression of TGF‑β. By contrast, upregulation of MMP‑28 induced cell growth and reduced the apoptosis of glioma cells by activating TGF‑β. In addition, the TGF‑β inhibitor attenuated the effects of MMP‑28 in glioma cells. Collectively, the results indicated that MMP‑28 was able to induce TGF‑β in human glioma cells.

References

1 

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, et al: Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): A randomised, double-blind, international phase 3 trial. Lancet Oncol. 18:1373–1385. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Blumenthal DT, Rankin C, Stelzer KJ, Spence AM, Sloan AE, Moore DF Jr, Padula GD, Schulman SB, Wade ML and Rushing EJ: A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001. Int J Clin Oncol. 20:650–658. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL and Okada H: Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas. J Clin Oncol. 32:2050–2058. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Eisenstat DD, Pollack IF, Demers A, Sapp MV, Lambert P, Weisfeld-Adams JD, Burger PC, Gilles F, Davis RL, Packer R, et al: Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945. J Neurooncol. 121:573–581. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Yan H, Wang W, Dou C, Tian F and Qi S: Securin promotes migration and invasion via matrix metalloproteinases in glioma cells. Oncol Lett. 9:2895–2901. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C and Saarialho-Kere U: Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci. 49:653–661. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Marchenko GN and Strongin AY: MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene. 265:87–93. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Pan YB, Zhang CH, Wang SQ, Ai PH, Chen K, Zhu L, Sun ZL and Feng DF: Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma. J Neurooncol. 137:395–407. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Guo Z, Li G, Bian E, Ma CC, Wan J and Zhao B: TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy. Biomed Pharmacother. 94:774–780. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Suomela S, Koljonen V, Skoog T, Kukko H, Böhling T and Saarialho-Kere U: Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma. Virchows Arch. 455:495–503. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Gencer S, Cebeci A and Irmak-Yazicioglu MB: Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines. Chin J Cancer Res. 25:322–333. 2013.PubMed/NCBI

13 

Manicone AM, Gharib SA, Gong KQ, Eddy WE, Long ME, Frevert CW, Altemeier WA, Parks WC and Houghton AM: Matrix metalloproteinase-28 is a key contributor to emphysema pathogenesis. Am J Pathol. 187:1288–1300. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Illman SA, Lohi J and Keski-Oja J: Epilysin (MMP-28)-structure, expression and potential functions. Exp Dermatol. 17:897–907. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Illman SA, Lehti K, Keski-Oja J and Lohi J: Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci. 119:3856–3865. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Rao S, Zaidi S, Banerjee J, Jogunoori W, Sebastian R, Mishra B, Nguyen BN, Wu RC, White J, Deng C, et al: Transforming growth factor-β in liver cancer stem cells and regeneration. Hepatol Commun. 1:477–493. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Åström P, Juurikka K, Hadler-Olsen ES, Svineng G, Cervigne NK, Coletta RD, Risteli J, Kauppila JH, Skarp S, Kuttner S, et al: The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. Br J Cancer. 117:1007–1016. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2018
Volume 16 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, X., Chen, X., Sun, L., Bi, X., He, H., Chen, L., & Pang, J. (2018). The function of MMP‑28/TGF‑β induced cell apoptosis in human glioma cells. Experimental and Therapeutic Medicine, 16, 2867-2874. https://doi.org/10.3892/etm.2018.6566
MLA
Wang, X., Chen, X., Sun, L., Bi, X., He, H., Chen, L., Pang, J."The function of MMP‑28/TGF‑β induced cell apoptosis in human glioma cells". Experimental and Therapeutic Medicine 16.4 (2018): 2867-2874.
Chicago
Wang, X., Chen, X., Sun, L., Bi, X., He, H., Chen, L., Pang, J."The function of MMP‑28/TGF‑β induced cell apoptosis in human glioma cells". Experimental and Therapeutic Medicine 16, no. 4 (2018): 2867-2874. https://doi.org/10.3892/etm.2018.6566